188 related articles for article (PubMed ID: 24101541)
1. Evaluation of venous thromboembolism prophylaxis in patients with chronic liver disease.
Smith CB; Hurdle AC; Kemp LO; Sands C; Twilla JD
J Hosp Med; 2013 Oct; 8(10):569-73. PubMed ID: 24101541
[TBL] [Abstract][Full Text] [Related]
2. Risk of hemorrhage in patients with chronic liver disease and coagulopathy receiving pharmacologic venous thromboembolism prophylaxis.
Reichert JA; Hlavinka PF; Stolzfus JC
Pharmacotherapy; 2014 Oct; 34(10):1043-9. PubMed ID: 25052037
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of pharmacologic prophylaxis for venous thromboembolism in patients with chronic liver disease.
Barclay SM; Jeffres MN; Nguyen K; Nguyen T
Pharmacotherapy; 2013 Apr; 33(4):375-82. PubMed ID: 23553808
[TBL] [Abstract][Full Text] [Related]
4. A Retrospective Cohort Analysis of Pharmacologic VTE Prophylaxis and Padua Prediction Score in Hospitalized Patients With Chronic Liver Disease.
Moorehead KJ; Jeffres MN; Mueller SW
J Pharm Pract; 2017 Feb; 30(1):58-63. PubMed ID: 26475125
[TBL] [Abstract][Full Text] [Related]
5. Risk of venous thromboembolism in patients with chronic liver disease and the utility of venous thromboembolism prophylaxis.
Pincus KJ; Tata AL; Watson K
Ann Pharmacother; 2012 Jun; 46(6):873-8. PubMed ID: 22570429
[TBL] [Abstract][Full Text] [Related]
6. Venous thromboembolism prophylaxis for medical service-mostly cancer-patients at hospital discharge.
Fanikos J; Rao A; Seger AC; Piazza G; Catapane E; Chen X; Goldhaber SZ
Am J Med; 2011 Dec; 124(12):1143-50. PubMed ID: 22114828
[TBL] [Abstract][Full Text] [Related]
7. Coagulopathy does not protect against venous thromboembolism in hospitalized patients with chronic liver disease.
Dabbagh O; Oza A; Prakash S; Sunna R; Saettele TM
Chest; 2010 May; 137(5):1145-9. PubMed ID: 20040609
[TBL] [Abstract][Full Text] [Related]
8. Thromboprophylaxis patterns, risk factors, and outcomes of care in the medically ill patient population.
Mahan CE; Fisher MD; Mills RM; Fields LE; Stephenson JJ; Fu AC; Spyropoulos AC
Thromb Res; 2013 Nov; 132(5):520-6. PubMed ID: 24080150
[TBL] [Abstract][Full Text] [Related]
9. Chemoprophylaxis for venous thromboembolism in otolaryngology.
Bahl V; Shuman AG; Hu HM; Jackson CR; Pannucci CJ; Alaniz C; Chepeha DB; Bradford CR
JAMA Otolaryngol Head Neck Surg; 2014 Nov; 140(11):999-1005. PubMed ID: 25275427
[TBL] [Abstract][Full Text] [Related]
10. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
Reeves D; Liu CY
J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
[TBL] [Abstract][Full Text] [Related]
11. A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital.
Wiseman DN; Harrison J
N Z Med J; 2010 Feb; 123(1309):37-49. PubMed ID: 20186241
[TBL] [Abstract][Full Text] [Related]
12. Risk-assessment and pharmacological prophylaxis of venous thromboembolism in hospitalized patients with chronic liver disease.
Bogari H; Patanwala AE; Cosgrove R; Katz M
Thromb Res; 2014 Dec; 134(6):1220-3. PubMed ID: 25294587
[TBL] [Abstract][Full Text] [Related]
13. Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial.
Hull RD; Schellong SM; Tapson VF; Monreal M; Samama MM; Nicol P; Vicaut E; Turpie AG; Yusen RD;
Ann Intern Med; 2010 Jul; 153(1):8-18. PubMed ID: 20621900
[TBL] [Abstract][Full Text] [Related]
14. Venous thromboembolism and underutilisation of anticoagulant thromboprophylaxis in hospitalised patients with inflammatory bowel disease.
Dwyer JP; Javed A; Hair CS; Moore GT
Intern Med J; 2014 Aug; 44(8):779-84. PubMed ID: 24893756
[TBL] [Abstract][Full Text] [Related]
15. Is low-molecular-weight heparin safe for venous thromboembolism prophylaxis in patients with traumatic brain injury? A Western Trauma Association multicenter study.
Kwiatt ME; Patel MS; Ross SE; Lachant MT; MacNew HG; Ochsner MG; Norwood SH; Speier L; Kozar R; Gerber JA; Rowell S; Krishnakumar S; Livingston DH; Manis G; Haan JM
J Trauma Acute Care Surg; 2012 Sep; 73(3):625-8. PubMed ID: 22929493
[TBL] [Abstract][Full Text] [Related]
16. Assessment of bleeding in chronic liver disease and coagulopathy using the IMPROVE bleeding criteria.
Chamoun N; Ramia E; Lteif C; Salameh P; Zantout H; Ghanem G; Chatila R
Curr Med Res Opin; 2019 Mar; 35(3):427-433. PubMed ID: 30221541
[TBL] [Abstract][Full Text] [Related]
17. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
Huo MH; Muntz J
Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of pharmacological thromboprophylaxis for hospitalized patients with cirrhosis: a single-center retrospective cohort study.
Shatzel J; Dulai PS; Harbin D; Cheung H; Reid TN; Kim J; James SL; Khine H; Batman S; Whyman J; Dickson RC; Ornstein DL
J Thromb Haemost; 2015 Jul; 13(7):1245-53. PubMed ID: 25955079
[TBL] [Abstract][Full Text] [Related]
19. Survival effects of inferior vena cava filter in patients with acute symptomatic venous thromboembolism and a significant bleeding risk.
Muriel A; Jiménez D; Aujesky D; Bertoletti L; Decousus H; Laporte S; Mismetti P; Muñoz FJ; Yusen R; Monreal M;
J Am Coll Cardiol; 2014 Apr; 63(16):1675-83. PubMed ID: 24576432
[TBL] [Abstract][Full Text] [Related]
20. Mechanical and suboptimal pharmacologic prophylaxis and delayed mobilization but not morbid obesity are associated with venous thromboembolism after total knee arthroplasty: a case-control study.
Sadeghi B; Romano PS; Maynard G; Strater AL; Hensley L; Cerese J; White RH
J Hosp Med; 2012; 7(9):665-71. PubMed ID: 23042665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]